公开(公告)号：US12053500B2

公开(公告)日：2024-08-06

申请号：US17644990

申请日：2021-12-17

申请人： Sami-Sabinsa Group Limited

发明人： Muhammed Majeed ,  Kalyanam Nagabhushanam ,  Lakshmi Mundkur ,  A. Muhamad Ibrahim

IPC分类号： A61K36/9066 ,  A23L33/105 ,  A61K9/00 ,  A61K9/20 ,  A61K9/48 ,  A61K31/12 ,  A61K31/19 ,  A61K31/23 ,  A61K36/324 ,  A61K47/12 ,  A61K47/26 ,  A61K47/42 ,  A61P3/06 ,  A61P19/02 ,  A61P39/06

CPC分类号： A61K36/9066 ,  A23L33/105 ,  A61K9/0053 ,  A61K9/0056 ,  A61K9/2009 ,  A61K9/2013 ,  A61K9/2054 ,  A61K9/2059 ,  A61K9/4866 ,  A61K31/12 ,  A61K31/19 ,  A61K31/23 ,  A61K36/324 ,  A61K47/12 ,  A61K47/26 ,  A61K47/42 ,  A61P3/06 ,  A61P19/02 ,  A61P39/06

摘要： A composition enriched with bisdemethoxycurcumin standardized to contain 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin. More specifically the invention discloses the potential of a composition comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin in the management of nephrotoxicity in mammals. The composition further comprises a Nigella sativa extract standardised to contain not less than 2% w/w thymoquinone and about 0.01%-10% w/w thymohydroquinone.

公开(公告)号：US20240216452A1

公开(公告)日：2024-07-04

申请号：US18545273

申请日：2023-12-19

申请人： Man Ki HWANG

发明人： Man Ki HWANG

IPC分类号： A61K36/232 ,  A61K31/473 ,  A61K36/21 ,  A61K36/234 ,  A61K36/254 ,  A61K36/284 ,  A61K36/324 ,  A61K36/328 ,  A61K36/344 ,  A61K36/40 ,  A61K36/46 ,  A61K36/481 ,  A61K36/484 ,  A61K36/53 ,  A61K36/64 ,  A61K36/65 ,  A61K36/734 ,  A61K36/752 ,  A61K36/815 ,  A61K36/8945 ,  A61K36/8998 ,  A61K36/9064

CPC分类号： A61K36/232 ,  A61K31/473 ,  A61K36/21 ,  A61K36/234 ,  A61K36/254 ,  A61K36/284 ,  A61K36/324 ,  A61K36/328 ,  A61K36/344 ,  A61K36/40 ,  A61K36/46 ,  A61K36/481 ,  A61K36/484 ,  A61K36/53 ,  A61K36/64 ,  A61K36/65 ,  A61K36/734 ,  A61K36/752 ,  A61K36/815 ,  A61K36/8945 ,  A61K36/8998 ,  A61K36/9064 ,  A61K2236/15 ,  A61K2236/17 ,  A61K2236/33 ,  A61K2236/39

摘要： Disclosed herein is a method for manufacturing a composition promoting bone density enhancement, the method including preparing a mixture of Angelica gigas, Cnidium officinale, Phlomis umbrosa, Astragalus membranceus, Amomi fructus, Citri unshius pericarpium, Drynariae rhizoma, Codonopsis pilosulae radix, frankincense, and myrrh, aging the mixture, drying the mixture and grinding the dried mixture into a powder, and extracting a liquid from the powder.

公开(公告)号：US20240216451A1

公开(公告)日：2024-07-04

申请号：US18390276

申请日：2023-12-20

申请人： Man Ki Hwang

发明人： Man Ki Hwang

IPC分类号： A61K36/232 ,  A61K36/126 ,  A61K36/234 ,  A61K36/324 ,  A61K36/328 ,  A61K36/344 ,  A61K36/481 ,  A61K36/53 ,  A61K36/752 ,  A61K36/9064 ,  A61P19/00

CPC分类号： A61K36/232 ,  A61K36/126 ,  A61K36/234 ,  A61K36/324 ,  A61K36/328 ,  A61K36/344 ,  A61K36/481 ,  A61K36/53 ,  A61K36/752 ,  A61K36/9064 ,  A61P19/00 ,  A61K2236/15 ,  A61K2236/333

摘要： Disclosed herein is a method for manufacturing a composition promoting recovery from a bone fracture, the method including preparing a mixture of Angelica gigas, Cnidium officinale, Phlomis umbrosa, Astragalus membranceus, Amomi fructus, Citri unshius pericarpium, Drynariae Rhizoma, Codonopsis Pilosulae Radix, frankincense, and myrrh, aging the mixture, smoking the mixture, drying the mixture and grinding the dried mixture into a powder, and extracting a liquid from the powder.

公开(公告)号：US20240100113A1

公开(公告)日：2024-03-28

申请号：US17951917

申请日：2022-09-23

申请人： QSI HOLDING COMPANY, INC

发明人： Ann-Celeste Billings

IPC分类号： A61K36/324 ,  A61K9/00 ,  A61K31/015 ,  A61K31/045 ,  A61K31/197 ,  A61K31/198 ,  A61K31/522 ,  A61K36/185 ,  A61K36/28 ,  A61K36/41 ,  A61K36/575 ,  A61K36/68 ,  A61K36/74 ,  A61K36/81

CPC分类号： A61K36/324 ,  A61K9/006 ,  A61K31/015 ,  A61K31/045 ,  A61K31/197 ,  A61K31/198 ,  A61K31/522 ,  A61K36/185 ,  A61K36/28 ,  A61K36/41 ,  A61K36/575 ,  A61K36/68 ,  A61K36/74 ,  A61K36/81

摘要： A composition for oral mucosal delivery can include at least two terpenes having anti-inflammatory properties, the at least two terpenes comprising at least one of terpinolene, beta caryophyllene, alpha pinene, linalool, alpha-terpineol, limonene; and at least two supplements having anti-inflammatory properties, the supplements comprising at least one of cat's claw root extract and boswellia root extract. In other embodiments, the composition can contain other terpenes and active compositions/supplements that have complementary effects.

公开(公告)号：US20240041962A1

公开(公告)日：2024-02-08

申请号：US18490805

申请日：2023-10-20

申请人： Imam Abdulrahman Bin Faisal University

发明人： Sahar K. AL-DOSARY

IPC分类号： A61K36/324 ,  A61P31/04 ,  A61K39/09 ,  A61K39/108

CPC分类号： A61K36/324 ,  A61P31/04 ,  A61K39/092 ,  A61K39/0266 ,  A61K2236/333 ,  A61K2039/876

摘要： A method for treating a microbial infection, especially pneumonia, comprising administering an aqueous-ethanol extract of Thymus or Boswellia or a composition containing the extract. Aqueous-ethanol extracts of Thymus and/or Boswellia.

公开(公告)号：US11890313B2

公开(公告)日：2024-02-06

申请号：US17929434

申请日：2022-09-02

申请人： HERBALIFE INTERNATIONAL, INC

发明人： Bruce L. Howe

IPC分类号： A61K36/9068 ,  A61K36/9066 ,  A61K36/324 ,  A61K9/127 ,  A61K31/685 ,  A61K31/56 ,  A61K31/12 ,  A61K9/14

CPC分类号： A61K36/9068 ,  A61K9/127 ,  A61K9/14 ,  A61K31/12 ,  A61K31/56 ,  A61K31/685 ,  A61K36/324 ,  A61K36/9066 ,  A61K36/324 ,  A61K2300/00 ,  A61K36/9066 ,  A61K2300/00 ,  A61K36/9068 ,  A61K2300/00

摘要： The invention is directed to natural drug compositions comprising turmeric, boswellia and ginger. Methods for the use of the inventive drug compositions in the treatment of inflammatory disorders and melanoma are within the scope of the invention.

公开(公告)号：US20230405056A1

公开(公告)日：2023-12-21

申请号：US18196018

申请日：2023-05-11

申请人： Lixi Xie

发明人： Lixi Xie

IPC分类号： A61K35/58 ,  C11B1/02 ,  C11B3/00 ,  A61K36/28 ,  A61K36/736 ,  A61K36/324 ,  A61K36/53 ,  A61K36/23 ,  A61K36/8962

CPC分类号： A61K35/58 ,  C11B1/02 ,  C11B3/008 ,  A61K36/28 ,  A61K36/736 ,  A61K36/324 ,  A61K36/53 ,  A61K36/23 ,  A61K36/8962

摘要： The present disclosure provides an extraction method of natural crocodile oil. The method improves the traditional ancient method of making oil, and includes: mixing crocodile fat with a traditional Chinese medicine bag and standing, then taking out the fat, and sequentially pulping and filtering. By using the above method, any extracts are not added without decolorization, the effective ingredients in the crocodile oil can be maintained to the greatest extent to the greatest extent, and therefore the method of the present disclosure is suitable for large-scale production. The present disclosure further provides the crocodile oil obtained by the extraction method. The crocodile oil is glittering and translucent, has no fishy smell, and can be preserved for a long time.

公开(公告)号：US11759492B2

公开(公告)日：2023-09-19

申请号：US15521212

申请日：2015-10-21

申请人： Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG

发明人： Matthias H. Kreuter ,  Michael Kemmler

IPC分类号： A61K36/324 ,  A61K45/06 ,  A23L33/105 ,  A61K8/9789 ,  A23L2/52 ,  A61K8/31 ,  A61K8/33 ,  A61K8/34 ,  A61K8/35 ,  A61K31/015 ,  A61K31/045 ,  A61K31/085 ,  A61K31/122 ,  A61Q19/00

CPC分类号： A61K36/324 ,  A23L2/52 ,  A23L33/105 ,  A61K8/31 ,  A61K8/33 ,  A61K8/342 ,  A61K8/35 ,  A61K8/9789 ,  A61K31/015 ,  A61K31/045 ,  A61K31/085 ,  A61K31/122 ,  A61K45/06 ,  A61Q19/00 ,  A61K2236/33 ,  A61K2800/10 ,  A61K36/324 ,  A61K2300/00

摘要： The invention relates to a novel extract from the resin of a plant of the genus Boswellia (Burseraceae). The invention further relates to a composition comprising the novel extract, in particular a pharmaceutical composition or a cosmetic composition, or a food supplement, a food or a beverage comprising the extract. Further, the invention concerns the use of the extract and the respective compositions, in particular the use of the extract or a composition comprising the extract in the cosmetic or therapeutic field as well as in food supplements. The invention also relates to the novel extract and the respective compositions for use in the treatment and/or prevention of a disease. A method of treatment and/or prevention of a neurodegenerative disease is further provided. A process is also provided, by which the novel extract is obtained.

公开(公告)号：US11738060B2

公开(公告)日：2023-08-29

申请号：US17707132

申请日：2022-03-29

申请人： Imam Abdulrahman Bin Faisal University

发明人： Sahar K. Al-Dosary

IPC分类号： A61K36/324 ,  A61K39/108 ,  A61K39/00 ,  A61P31/04 ,  A61K39/09

CPC分类号： A61K36/324 ,  A61K39/0266 ,  A61K39/092 ,  A61P31/04 ,  A61K2039/876 ,  A61K2236/333

摘要： A method for treating a microbial infection, especially pneumonia, comprising administering an aqueous-ethanol extract of Thymus or Boswellia or a composition containing the extract. Aqueous-ethanol extracts of Thymus and/or Boswellia.

公开(公告)号：US20230226082A1

公开(公告)日：2023-07-20

申请号：US17985097

申请日：2022-11-10

申请人： Bioved Pharmaceuticals, Inc.

发明人： Deepa Chitre ,  Debendranath Dey ,  Satej R Nadkarni

IPC分类号： A61K31/585 ,  A61K31/19 ,  A61K31/12 ,  A61K36/9068 ,  A61K36/9066 ,  A61K36/324 ,  A61K36/81 ,  A61K31/675 ,  A61K31/4025 ,  A61K31/375 ,  A61K33/30 ,  A61K31/198 ,  A61K9/20 ,  A61K9/16 ,  A61P31/14 ,  A61P27/00

CPC分类号： A61K31/585 ,  A61K31/19 ,  A61K31/12 ,  A61K36/9068 ,  A61K36/9066 ,  A61K36/324 ,  A61K36/81 ,  A61K31/675 ,  A61K31/4025 ,  A61K31/375 ,  A61K33/30 ,  A61K31/198 ,  A61K9/2059 ,  A61K9/2009 ,  A61K9/2027 ,  A61K9/1611 ,  A61K9/1652 ,  A61P31/14 ,  A61P27/00 ,  A61K2236/333 ,  A61K2236/53

摘要： Methods and formulations for treating and preventing LONG COVID sequelae are provided. An example method treats loss of smell and taste from SARS-CoV-2 infection, including assessing the patient, administering a composition with dosage between 1750-3600 mg per day, wherein the composition comprises a mixture of at least a withanolide-A, a boswellic acid, a [6]-gingerol, and a curcuminoid. Another example method treats memory loss or brain fog from SARS-CoV-2 infection, including assessing the patient, and administering a regenerative and neuroprotective composition comprising a mixture of withanoside VI, withanolide A, a Boswellia serrata plant, a Zingiber officinale rhizome, and a Curcuma longa rhizome. The compositions were found effective, achieving statistical significance in a multi-center, randomized, double-blind, placebo-controlled phase III clinical trial.